Cormorant Asset Management as of June 30, 2024
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 49 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 21.6 | $374M | 8.5M | 43.97 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 5.3 | $92M | 2.0M | 45.25 | |
| Arcellx Common Stock (ACLX) | 4.9 | $84M | 1.5M | 55.19 | |
| Vaxcyte (PCVX) | 4.8 | $83M | 1.1M | 75.51 | |
| Longboard Pharmaceuticals In | 4.4 | $75M | 2.8M | 27.03 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 4.2 | $72M | 8.3M | 8.70 | |
| Rapport Therapeutics (RAPP) | 4.0 | $68M | 2.9M | 23.26 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.5 | $61M | 1.4M | 44.79 | |
| Edgewise Therapeutics (EWTX) | 3.1 | $54M | 3.0M | 18.01 | |
| Merus N V (MRUS) | 2.9 | $50M | 840k | 59.17 | |
| Bridgebio Pharma (BBIO) | 2.7 | $47M | 1.9M | 25.33 | |
| Insmed Com Par $.01 (INSM) | 2.6 | $45M | 675k | 67.00 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 2.6 | $44M | 2.3M | 19.21 | |
| Janux Therapeutics (JANX) | 2.5 | $44M | 1.1M | 41.89 | |
| Axsome Therapeutics (AXSM) | 1.9 | $32M | 400k | 80.50 | |
| Cg Oncology (CGON) | 1.8 | $31M | 975k | 31.57 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.7 | $30M | 2.9M | 10.22 | |
| Alumis (ALMS) | 1.6 | $29M | 2.1M | 13.30 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.6 | $28M | 685k | 41.36 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.6 | $28M | 2.1M | 13.22 | |
| Biohaven (BHVN) | 1.6 | $28M | 802k | 34.71 | |
| Urogen Pharma (URGN) | 1.6 | $28M | 1.7M | 16.78 | |
| Pharvaris N V (PHVS) | 1.6 | $28M | 1.5M | 18.80 | |
| Arcutis Biotherapeutics (ARQT) | 1.4 | $24M | 2.5M | 9.30 | |
| Sarepta Therapeutics (SRPT) | 1.1 | $20M | 125k | 158.00 | |
| Cullinan Oncology (CGEM) | 1.1 | $20M | 1.1M | 17.44 | |
| Rhythm Pharmaceuticals (RYTM) | 1.1 | $20M | 475k | 41.06 | |
| Cargo Therapeutics (CRGX) | 1.1 | $19M | 1.2M | 16.42 | |
| Y Mabs Therapeutics (YMAB) | 1.0 | $18M | 1.5M | 12.08 | |
| Avidity Biosciences Ord (RNA) | 1.0 | $17M | 425k | 40.85 | |
| Biomea Fusion (BMEA) | 0.9 | $16M | 3.6M | 4.50 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.8 | $15M | 1.6M | 9.03 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $14M | 500k | 27.18 | |
| Silence Therapeutics Ads (SLN) | 0.7 | $12M | 625k | 19.00 | |
| Arrivent Biopharma (AVBP) | 0.6 | $9.6M | 515k | 18.55 | |
| Engene Holdings (ENGN) | 0.5 | $9.4M | 1.0M | 9.43 | |
| Korro Bio (KRRO) | 0.5 | $9.0M | 266k | 33.87 | |
| Ideaya Biosciences (IDYA) | 0.5 | $8.6M | 245k | 35.11 | |
| Immunitybio Put Option (IBRX) | 0.5 | $7.9M | 1.3M | 6.32 | |
| Gh Research Ordinary Shares (GHRS) | 0.4 | $6.9M | 593k | 11.66 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.3 | $6.0M | 75k | 80.29 | |
| Stoke Therapeutics (STOK) | 0.3 | $5.8M | 427k | 13.51 | |
| Mersana Therapeutics (MRSN) | 0.3 | $5.2M | 2.6M | 2.01 | |
| Neurogene (NGNE) | 0.2 | $3.9M | 107k | 36.39 | |
| SIGA Technologies Put Option (SIGA) | 0.2 | $3.8M | 500k | 7.59 | |
| Vyne Therapeutics (VYNE) | 0.2 | $2.7M | 1.4M | 1.97 | |
| Compass Therapeutics (CMPX) | 0.1 | $2.0M | 2.0M | 1.00 | |
| Verve Therapeutics (VERV) | 0.1 | $1.7M | 350k | 4.88 | |
| Rapt Therapeutics (RAPT) | 0.1 | $1.5M | 497k | 3.05 |
